| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 2,6 M € | -23.2% | 3,4 M € | +5.2% | 3,2 M € | +10.8% | 2,9 M € | — | — | — | — | — | — | — | — | — | — | |||||||||||||||
| Gross margin | 1,6 M € | +4.4% | 1,6 M € | +7.1% | 1,5 M € | +37.9% | 1,1 M € | +5.4% | 1,0 M € | -22.3% | 1,3 M € | +1.3% | 1,3 M € | +14.6% | 1,1 M € | -7.5% | 1,2 M € | +11.9% | 1,1 M € | -7.5% | 1,2 M € | +19.4% | 976,9 k € | -13.5% | 1,1 M € | +5.6% | 1,1 M € | +7.7% | 992,8 k € | -9.1% | 1,1 M € | +7.7% | 1,0 M € | +12.7% | 899,8 k € | |
| EBITDA | 410,8 k € | +56.0% | 263,3 k € | +0.8% | 261,2 k € | +136.8% | 110,3 k € | +12.1% | 98,4 k € | -64.2% | 274,9 k € | -33.7% | 414,5 k € | +61.5% | 256,7 k € | -1.5% | 260,5 k € | +11.9% | 232,8 k € | -24.4% | 307,9 k € | +39.4% | 220,9 k € | -41.8% | 379,3 k € | -16.1% | 452,1 k € | -11.8% | 512,7 k € | -5.7% | 543,8 k € | +40.8% | 386,1 k € | +16.4% | 331,7 k € | |
| Operating profit | 143,0 k € | +100.2% | 71,5 k € | -37.6% | 114,4 k € | +722.9% | 13,9 k € | -54.5% | 30,6 k € | -84.1% | 191,9 k € | -33.1% | 286,7 k € | +143.1% | 117,9 k € | -2.3% | 120,7 k € | -8.2% | 131,5 k € | -43.0% | 230,6 k € | +20.2% | 191,8 k € | -45.7% | 353,0 k € | -12.8% | 405,0 k € | +1.8% | 398,0 k € | -7.1% | 428,3 k € | +55.7% | 275,0 k € | +62.7% | 169,0 k € | |
| Profit/loss | 82,3 k € | +358.5% | 18,0 k € | -71.3% | 62,6 k € | -12.5% | 71,6 k € | +471.2% | 12,5 k € | -89.8% | 123,4 k € | -22.8% | 159,8 k € | +286.8% | 41,3 k € | -26.1% | 55,9 k € | +9.7% | 51,0 k € | -55.3% | 114,2 k € | -19.1% | 141,1 k € | -30.1% | 201,7 k € | -9.2% | 222,2 k € | +10.4% | 201,3 k € | -9.3% | 222,0 k € | +17.4% | 189,1 k € | +119.4% | 86,2 k € | |
| Equity | 2,4 M € | +3.5% | 2,3 M € | +0.8% | 2,3 M € | +2.8% | 2,3 M € | +4.9% | 2,2 M € | +0.6% | 2,1 M € | +6.1% | 2,0 M € | +8.6% | 1,9 M € | +2.3% | 1,8 M € | +3.2% | 1,8 M € | +3.0% | 1,7 M € | +7.1% | 1,6 M € | +9.7% | 1,5 M € | +16.0% | 1,3 M € | +21.5% | 1,0 M € | +24.1% | 833,6 k € | +36.3% | 611,6 k € | +1.5% | 602,5 k € | |
| Total assets | 3,9 M € | +6.0% | 3,7 M € | -3.4% | 3,8 M € | +10.8% | 3,5 M € | +10.6% | 3,1 M € | -5.3% | 3,3 M € | +3.1% | 3,2 M € | +0.1% | 3,2 M € | -1.3% | 3,2 M € | +3.8% | 3,1 M € | -0.4% | 3,1 M € | +8.8% | 2,9 M € | -2.0% | 2,9 M € | +9.2% | 2,7 M € | -5.8% | 2,9 M € | +2.3% | 2,8 M € | +1.9% | 2,7 M € | +3.4% | 2,7 M € | |
| Cash | 962,2 € | -63.1% | 2,6 k € | +20.5% | 2,2 k € | -83.0% | 12,8 k € | +277.4% | 3,4 k € | +77.7% | 1,9 k € | +72.6% | 1,1 k € | -20.3% | 1,4 k € | -70.3% | 4,7 k € | -82.9% | 27,3 k € | +646.3% | 3,7 k € | -78.3% | 16,8 k € | +101.6% | 8,3 k € | +69.3% | 4,9 k € | -46.0% | 9,1 k € | -26.8% | 12,5 k € | +36.5% | 9,1 k € | -38.2% | 14,8 k € | |
| Debts | 1,5 M € | +10.4% | 1,4 M € | -10.0% | 1,5 M € | +25.9% | 1,2 M € | +23.1% | 970,3 k € | -16.2% | 1,2 M € | -2.1% | 1,2 M € | -11.8% | 1,3 M € | -5.8% | 1,4 M € | +4.7% | 1,4 M € | -4.5% | 1,4 M € | +11.0% | 1,3 M € | -10.4% | 1,4 M € | +8.9% | 1,3 M € | -19.5% | 1,6 M € | +2.4% | 1,6 M € | -5.9% | 1,7 M € | +2.8% | 1,6 M € | |
| Staff | 20,3 | 20,2 | 18,1 | 15,2 | — | 17,1 | 15,8 | 15,6 | 17 | 15,7 | 16,4 | 13 | 12,4 | 11,2 | 10,6 | 11,2 | 11,5 | 12,8 | ||||||||||||||||||
Public limited company · Hamont-Achel · incorporated on 14/04/1993 · 20,3 ETP
Public limited company profitable and well capitalised. Cash position declining (-63.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MONDOMED is a Public limited company incorporated in 1993. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Hamont-Achel. It employs on average 20,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette